Review



emt6 cells  (Charles River Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Charles River Laboratories emt6 cells
    Emt6 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/balb+c+mice/pm42171604-208-28-30
    Average 86 stars, based on 1 article reviews
    emt6 cells - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Inhibition:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Selection:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    In Vitro:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    RNA Sequencing:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Quantitative RT-PCR:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Two Tailed Test:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Control:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Imaging:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Standard Deviation:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Gene Expression:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Protein Array:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Knockdown:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Expressing:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Western Blot:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Enzyme-linked Immunosorbent Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Plasmid Preparation:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Flow Cytometry:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Immunopeptidomics:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    shRNA:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Activation Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Derivative Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Staining:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Incubation:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Marker:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Co-Culture Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Variant Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Purification:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Recombinant:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Red Blood Cell Lysis:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Membrane:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Isolation:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    DC Protein Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Amplification:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Software:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Spectrophotometry:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Lysis:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Protease Inhibitor:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    SYBR Green Assay:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    cDNA Synthesis:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Transfection:

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
    Article Snippet: EMT6 (5 × 10 5 cells in 100 μl RPMI), RENCA (4 × 10 4 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8-week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I

    Article Title: Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
    Article Snippet: EMT6 (5 × 105 cells in 100 μl RPMI), RENCA (4 × 104 cells in 5 μl 1:1 RPMI:Matrigel) were implanted orthotopically into the right inguinal mammary fad pad or left kidney subcapsular space respectively in 6–8- week-old female NCI Balb/cAnNCr (Balb/c) mice (Charles River, USA). .. I



    Similar Products

    murine triple negative breast cancer cells  (ATCC)
    99
    ATCC murine triple negative breast cancer cells
    Murine Triple Negative Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/EMT6/pm42285093-303-1-26
    Average 99 stars, based on 1 article reviews
    murine triple negative breast cancer cells - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    emt6  (ATCC)
    99
    ATCC emt6
    Emt6, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/EMT6/pm42274627-50-0-1
    Average 99 stars, based on 1 article reviews
    emt6 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    emt6 casp3  (Boehringer Ingelheim)
    86
    Boehringer Ingelheim emt6 casp3
    Emt6 Casp3, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/casp3+emt6/10__1016_slash_j__omton__2026__201264-253-2-13
    Average 86 stars, based on 1 article reviews
    emt6 casp3 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    emt6 cell lines  (ATCC)
    99
    ATCC emt6 cell lines
    Emt6 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/EMT6/pm42217372-299-13-19
    Average 99 stars, based on 1 article reviews
    emt6 cell lines - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    emt6 cells  (Procell Inc)
    86
    Procell Inc emt6 cells
    Emt6 Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/0573+cl+emt6+purchase/10__1002_slash_adfm__76234-234-7-12
    Average 86 stars, based on 1 article reviews
    emt6 cells - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    emt6 cells  (Charles River Laboratories)
    86
    Charles River Laboratories emt6 cells
    Emt6 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/balb+c+mice/pm42171604-208-28-30
    Average 86 stars, based on 1 article reviews
    emt6 cells - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    emt6  (Cellseed Inc)
    86
    Cellseed Inc emt6
    Emt6, supplied by Cellseed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/emt6/emt6/pm42151127-295-7-23
    Average 86 stars, based on 1 article reviews
    emt6 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results